|
1
|
Sharma C, Nusri Qel-A, Begum S, et al:
(−)-Epigallocatechin-3-gallate induces apoptosis and inhibits
invasion and migration of human cervical cancer cells. Asian Pac J
Cancer Prev. 13:4815–4822. 2012.
|
|
2
|
Wobus M, Kuns R, Wolf C, Horn LC, Köhler
U, Sheyn I, Werness BA and Sherman LS: CD44 mediates constitutive
type I receptor signaling in cervical carcinoma cells. Gynecol
Oncol. 83:227–234. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu JH, Liang XA, Wu YM, Li FS and Dai YM:
Identification of DNA methylation of SOX9 in cervical cancer using
methylated-CpG island recovery assay. Oncol Rep. 29:125–132.
2013.PubMed/NCBI
|
|
4
|
Wu SF, Qian WY, Zhang JW, Yang YB, Liu Y,
Dong Y, Zhang ZB, Zhu YP and Feng YJ: Network motifs in the
transcriptional regulation network of cervical carcinoma cells
respond to EGF. Arch Gynecol Obstet. 287:771–777. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saavedra KP, Brebi PM and Roa JC:
Epigenetic alterations in preneoplastic and neoplastic lesions of
the cervix. Clin Epigenetics. 4:132012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Wang Q, Liu H, Shao N, Tan B,
Zhang G, Wang K, Jia Y, Ma W, Wang N and Cheng Y: The association
of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with
cancer risk: a meta-analysis of 32 studies. Mutagenesis.
27:779–788. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maddox J, Shakya A, South S, Shelton D,
Andersen JN, Chidester S, Kang J, Gligorich KM, Jones DA, Spangrude
GJ, Welm BE and Tantin D: Transcription factor Oct1 is a somatic
and cancer stem cell determinant. PLoS Genet. 8:e10030482012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin R, Li X and Li J, Zhang L, Xu F, Chu Y
and Li J: Long-term cisplatin exposure promotes methylation of the
OCT1 gene in human esophageal cancer cells. Dig Dis Sci.
58:694–698. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sturm RA, Cassady JL, Das G, Romo A and
Evans GA: Chromosomal structure and expression of the human OTF1
locus encoding the Oct-1 protein. Genomics. 16:333–341. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
11
|
Wang YW, Zheng D, Peng S, Xiong W, Ma J,
Zeng Z, Wu M, Zhou M, Xiang J, Xiang B, Li X, Li X and Li G: Risk
of nasopharyngeal carcinoma associated with polymorphic
lactotransferrin haplotypes. Med Oncol. 29:1456–1462. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ruan L, Wang GL, Chen Y, Yi H, Tang CE,
Zhang PF, Li MY, Li C, Peng F, Li JL, Chen ZC and Xiao ZQ:
Identification of tyrosine phosphoproteins in signaling pathway
triggered TGF-a by using functional proteomics technology. Med
Oncol. 27:1407–1414. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mariani L and Venuti A: HPV vaccine: an
overview of immune respose, clinical protections, and new
approaches for the future. J Trans Med. 8:1052010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peralta-Zaragoza O, Bermúdez-Morales VH,
Pérez-Plasencia C, Salazar-León J, Gómez-Cerón C and Madrid-Marina
V: Targeted treatments for cervical cancer: a review. Onco Targets
Ther. 5:315–328. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu Y, Zheng Y, Mei L, Liu M, Li S, Xiao
H, Zhu H, Wu S, Chen H and Huang L: Enhanced immunotherapeutic
effect of modified HPV16 E7-pulsed dendritic cell vaccine by an
adeno-shRNA-SOCS1 virus. Int J Oncol. 43:1151–1159. 2013.PubMed/NCBI
|
|
17
|
Bonito NA, Drechsler J, Stoecker S, Carmo
CR, Seckl MJ, Hermanns HM and Costa-Pereira AP: Control of gp130
expression by the mitogen-activated protein kinase ERK2. Oncogene.
May 20–2013.(Epub ahead of print).
|
|
18
|
Kim YW, Bae SM, Kim YW, Park DC, Lee KH,
Liu HB, Kim IW, Jang CK and Ahn WS: Target-based molecular
signature characteristics of cervical adenocarcinoma and squamous
cell carcinoma. Int J Oncol. 43:539–547. 2013.PubMed/NCBI
|
|
19
|
Norman I, Hjerpe A and Andersson S:
High-risk HPV L1 capsid protein as a marker of cervical
intraepithelial neoplasia in high-risk HPV-positive women with
minor cytological abnormalities. Oncol Rep. 30:695–700. 2013.
|
|
20
|
Yuan Y, Zhang J, Cai L, et al: Leptin
induces cell proliferation and reduces cell apoptosis by activating
c-myc in cervical cancer. Oncol Rep. 29:2291–2296. 2013.PubMed/NCBI
|
|
21
|
Porameesanaporn Y,
Uthaisang-Tanechpongtamb W, Jarintanan F, Jongrungruangchok S and
Thanomsub Wongsatayanon B: Terrein induces apoptosis in HeLa human
cervical carcinoma cells through p53 and ERK regulation. Oncol Rep.
29:1600–1608. 2013.
|
|
22
|
Gupta S, Wulf G, Henjakovic M, Koepsell H,
Burckhardt G and Hagos Y: Human organic cation transporter 1 is
expressed in lymphoma cells and increases susceptibility to
irinotecan and paclitaxel. J Pharmacol Exp Ther. 341:16–23. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hwang-Verslues WW, Chang PH, Jeng YM, Kuo
WH, Chiang PH, Chang YC, Hsieh TH, Su FY, Lin LC, Abbondante S,
Yang CY, Hsu HM, Yu JC, Chang KJ, Shew JY, Lee EY and Lee WH: Loss
of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT
gene expression and enhances tumor malignancy. Proc Natl Acad Sci
USA. 110:12331–12336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Obinata D, Takayama K, Urano T, Murata T,
Kumagai J, Fujimura T, Ikeda K, Horie-Inoue K, Homma Y, Ouchi Y,
Takahashi S and Inoue S: Oct1 regulates cell growth of LNCaP cells
and is a prognostic factor for prostate cancer. Int J Cancer.
130:1021–1028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang J, Shakya A and Tantin D: Stem cells,
stress, metabolism and cancer: a drama in two Octs. Trends Biochem
Sci. 34:491–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jariwala U, Cogan JP, Jia L, Frenkel B and
Coetzee GA: Inhibition of AR-mediated transcription by binding of
Oct1 to a motif enriched in AR-occupied regions. Prostate.
69:392–400. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shakya A, Kang J, Chumley J, Williams MA
and Tantin D: Oct1 is a switchable, bipotential stabilizer of
repressed and inducible transcriptional states. J Biol Chem.
286:450–459. 2011. View Article : Google Scholar : PubMed/NCBI
|
